Many women with ADHD say their symptoms get harder to manage around perimenopause and menopause. Some recent studies support that, including one from Ireland. But the evidence is young, it does not all agree, and no treatment trials have been done in this group yet.
Here is the short version:
This page sets out what the studies actually found, where the gaps are, and what you can do now.
Perimenopause is the run-up to menopause, when periods change and eventually stop. The NHS says it usually affects women between 45 and 55, though it can happen earlier. Both the NHS and HSE list memory and concentration problems ("brain fog") and mood changes among its symptoms.
Researchers have a working theory for why this could hit harder in ADHD. A 2025 review by a European group of ADHD researchers notes that oestrogen influences dopamine, a brain chemical involved in ADHD. They suggest that falling oestrogen may compound existing differences in dopamine signalling. That is a hypothesis, not an established mechanism. For the wider science on menopause and thinking, see perimenopause brain fog.
An Irish interview study in 2026 spoke to 19 women with ADHD aged 29 to 62. Themes included sudden emotional and cognitive changes, physical and sexual symptoms, and frustration with healthcare. Participants wanted perimenopause care that took their ADHD into account. Some also described perimenopause bringing new self-understanding and compassion.
The gaps are large, and two recent expert reviews say so plainly.
Menopause symptoms and ADHD overlap, which makes this hard to untangle.
The NICE guideline on ADHD says symptoms should have begun in childhood and persisted throughout life. So a clinician will ask about your childhood and earlier adult life, not just the past year.
That said, many women are diagnosed late. NICE notes that ADHD is thought to be under-recognised in girls and women. The NHS says this may be because women more often have inattentive symptoms, which are harder to spot. A 2026 review describes perimenopause as a time that can "exacerbate or unmask" underlying ADHD. Our articles on ADHD in women and late diagnosis explore why.
Two small US trials tested ADHD medicines in perimenopausal and postmenopausal women without ADHD. These women had new, midlife-onset problems with attention and memory.
These were small, short studies in women who did not have ADHD. They are not evidence that midlife memory problems are ADHD. UK product information for Elvanse Adult (lisdexamfetamine) limits its licence to adults whose ADHD symptoms were present in childhood.
Night sweats and poor sleep can worsen concentration for anyone. Sleep problems are also common in ADHD. See perimenopause and sleep.
Note when symptoms shift: your cycle, sleep, mood, focus and how well any ADHD medication seems to work. Patterns over a few months are more useful to a doctor than a single bad week.
The HSE and NHS both advise talking to a GP if menopause symptoms are hard to manage. In the UK, NICE says doctors can identify perimenopause in otherwise healthy women aged 45 or over from symptoms, without blood tests.
For menopause symptoms, NICE's menopause guideline (NG23) includes options such as:
These are treatments for menopause symptoms, not for ADHD.
Tell your ADHD prescriber if things change. Do not change your medication dose yourself. There is no trial-based guidance yet on adjusting ADHD medicines in midlife, so changes should be made with your prescriber. Our guide to ADHD medication for adults in Ireland covers how prescribing works.
Ask yourself whether the difficulties go back to childhood, not only to recent years. Gather school reports or ask family what you were like. Then talk to your GP about whether an ADHD assessment makes sense.
Some of the newest research in this area comes from Ireland. The 602-woman survey and the 19-woman interview study were both led from University College Dublin. They were linked to ADHD Ireland and the HSE National Clinical Programme for ADHD in Adults.
ADHD Ireland ran an online Women's Health and ADHD series in 2026, including a session on perimenopause in June. The charity's page describes it as research-informed and linked to that Irish research.
The NHS menopause pages describe perimenopause symptoms and when to see a GP. NICE's menopause guideline was last updated in April 2026.
Low mood around menopause can be serious. If you are thinking about suicide or self-harm, get help now.
Possibly, for some women. Two large studies found women with ADHD reported more severe menopausal symptoms. One UK-based study found no difference. No study has yet followed women with ADHD through menopause to measure changes directly.
No. ADHD starts in childhood. But perimenopause may make long-standing ADHD more noticeable, and some women are first diagnosed in midlife. Menopause itself can also cause memory and concentration problems.
This has not been tested in trials. NICE says HRT can be considered for low mood linked to menopause. Whether it helps ADHD symptoms specifically is unknown, and researchers list it as a priority to study.
There is no trial evidence to guide this yet. A 2026 review found no randomised trials in perimenopausal or menopausal women. Talk to your prescriber if your symptoms or side effects change.
You can read about Proco's planned assessment service on our assessments page.
This article is general information, not medical advice. It cannot diagnose ADHD or menopause. Talk to your GP or prescriber about your own situation, and never stop or change a medicine without their advice.
Reviewed by: Proco Team
Last updated: November 2026